Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.585
-0.015 (-0.95%)
Sep 2, 2026, 2:23 PM EDT - Market open
Imunon Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
8.89M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 500.00K | - | - |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | 500.00K | - | - |
| Dec 31, 2019 | 500.00K | - | - |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | 500.00K | - | - |
| Dec 31, 2016 | 500.00K | - | - |
| Dec 31, 2015 | 500.00K | - | - |
| Dec 31, 2014 | 500.00K | - | - |
| Dec 31, 2013 | 500.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 2.00M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | 2.50M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Immuron | 5.34M |
| Xenetic Biosciences | 3.26M |
| Traws Pharma | 2.73M |
| Exicure | 500.00K |
| AIM ImmunoTech | 95.00K |
| Soligenix | 2.34K |
IMNN News
- 7 days ago - IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 - GlobeNewsWire
- 22 days ago - Imunon Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - Imunon Earnings release: Q2 2026 - Filings
- 22 days ago - Imunon Quarterly report: Q2 2026 - Filings
- 22 days ago - Imunon reports Q2 EPS (54c), consensus (50c) - TheFly
- 4 weeks ago - Imunon provides update on OVATION 3 trial of IMNN-001 - TheFly
- 4 weeks ago - IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewsWire
- 5 weeks ago - IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development - GlobeNewsWire